Faron Pharmaceuticals Oy Subscription Rights (DI) (FRNP)

  0.15
   
  • Change Today:
     0.00
  • 52 Week High:  0.15
  • 52 Week Low:  0.01
  • Currency: Euro
  • Volume: 41,540

FRNP Overview

We are a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system in order to tackle cancer and inflammation. Since our founding in 2007, our goal has been to develop a diverse and unique pipeline rooted in high quality science and innovation. Faron is focused on mastering immune modulation by harnessing endothelial receptors to control and mediate immune responses.

3 Month Chart

3 Month Chart

1 Year Chart

1 Year Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Price Changes

Period Price Change Percent Change
1 week  0.00  0.00 n/a
1 month  0.00  0.00 n/a
3 months  0.00  0.00 n/a
6 months  0.00  0.00 n/a
1 year  0.00  0.00 n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Forecast figures based on normalised accounts.

 

FRNP Market Data

Currency Euro
Price   0.15
Change Today   0.00
% Change 0.00 %
52 Week High  0.15
52 Week Low  0.01
Volume 41,540

FRNP Dividends

No dividends found

Trades for 18-Mar-2026

Time Volume / Share Price
17:10 41,540 @  0.01

FRNP Key Personnel

CEO Juho Jalkanen
Chair Tuomo Pätsi
CFO Jurriaan Dekkers

Top of Page